Tirzepatide Canada supply at 30 mg, sold as a sealed kit of 10 vials — 300 mg total per box. Tirzepatide is a synthetic 39-amino-acid peptide with CAS number 2023788-19-2, molecular formula C225H348N48O68 and a molecular weight of 4814.6 g/mol. It is described in published literature as a dual receptor agonist.
This is the highest-strength listing. The same compound is available as a 10 mg kit and a 15 mg kit, all tested to the same specification.
Specification
- CAS: 2023788-19-2
- Molecular formula: C225H348N48O68
- Molecular weight: 4814.6 g/mol
- Form: lyophilized powder
- Kit size: 10 vials × 30 mg (300 mg total)
- Purity specification: minimum 98% chromatographic purity
- Label accuracy specification: minimum 90% net peptide content
- Storage: 2–8°C, protected from light
- Labelling: box-level, with batch QR
Ordering and kit format
Sold by the kit only. We do not break kits or sell single vials, which is how the per-vial cost stays where it is — you are buying at box economics rather than retail single-vial pricing.
Minimum order is three kits, which you can mix and match across any products in the catalogue. You do not need three kits of the same compound. Volume pricing applies from ten kits.
Labelling is at the box level. Each box carries the product name, the batch code, and a QR code that resolves to the certificate of analysis for that specific batch. The vials inside are unlabelled. This matters particularly here: we list this compound at three strengths, and a 10 mg, 15 mg and 30 mg vial are indistinguishable once separated from their boxes. Keep each kit with its own box.
How Tirzepatide Canada stock is tested
Every batch is independently analyzed by Peptide Test Canada, a licensed laboratory in Mississauga, Ontario. Samples are tested on Canadian soil. Nothing crosses a border to be verified.
That matters for more than principle. Domestic testing means no cross-border sample shipping, no customs delay on verification, and results under Canadian privacy law. It also means the lab is reachable, in your time zone, if a reseller or an end customer wants to confirm something directly.
PTC’s analytical chemists perform HPLC purity analysis and LC-MS/MS identity confirmation using methods validated following USP principles, with every result reviewed by a qualified scientist before the certificate is issued. Certificates include the raw HPLC chromatography data, not just a summary figure.
Our release specification is identical across all three strengths — a higher-strength vial is not held to a looser standard.
Reading your Tirzepatide Canada certificate
Chromatographic purity is measured as a percentage of total integrated peak area (Ph. Eur. 2.2.46) and bounds peptide-related impurities only. It does not account for excipients, counter-ions, or residual water.
Net peptide content is reported separately and tells you how much peptide is actually in each vial. On a higher-strength listing this is the figure to read in milligrams rather than percentage: the same percentage represents a larger absolute quantity as the claim rises.
Identity is confirmed by precursor mass with matched quantifier and qualifier transitions. A purity percentage alone does not establish that what is in the vial is what is on the label.
Verification you can pass on
Scanning the QR on the box returns that batch’s certificate, hosted at the laboratory’s own domain rather than ours. Anyone you supply can scan the same code and see the same result directly from the lab. Nothing routes through our servers, which means the verification stands independently of anything we say about it.
That is the practical difference between a supplier who says material is tested and one who hands you something checkable by the person you sell it to.
Tirzepatide Canada storage and fulfilment
Store refrigerated at 2–8°C, protected from light. Avoid repeated freeze-thaw cycles. Allow vials to reach room temperature before opening to prevent condensation inside the seal. Handling should be carried out by qualified personnel in accordance with applicable institutional policies.
Shipped domestically within Canada from Canadian stock — no cross-border transit, no customs handling, no inbound seizure exposure.
Full method detail and lab credentials are on our testing page.
Supplied for laboratory research use only. This material is not supplied as a drug product, is not a substitute for any authorized medicine, and is not for human or veterinary administration, clinical or diagnostic use. No dosage, reconstitution, preparation or administration guidance is provided or implied.








Reviews
There are no reviews yet.